Sort
40,608 grants matching “prostate cancer”
Comprehensive SDSU-UCSD Cancer Center Partnership (2 of 2)
$1,438,166Ana M Navarro · University Of California, San Diego · U54 · FY2009 · CA
Interrogating Epigenetic Changes in Cancer Genomes
$1,436,990Tim H.-M. Huang · University Of Texas Hlth Science Center · U54 · FY2013 · CA
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER
$1,436,423University Of Utah · N01 · FY2000 · CN
The Biology of Prostate Cancer Skeletal Metastases
$1,434,433Evan Todd Keller · University Of Michigan At Ann Arbor · P01 · FY2007 · CA
The Biology of Prostate Cancer Skeletal Metastases
$1,433,998University Of Michigan At Ann Arbor · P01 · FY2005 · CA
Prostate Cancer: Transition to Androgen - Independence (CA77739)
$1,433,904Frank S French · Univ Of North Carolina Chapel Hill · P01 · FY2014 · CA
Anti-carcinogenic Activity Of Cox inhibitors and NAG-1
$1,433,826Thomas Eling · Environmental Health Sciences · Z01 · FY2007 · ES
Center of Excellence in Eliminating Disparities
$1,432,422Elizabeth Ann Calhoun · University Of Illinois At Chicago · P60 · FY2010 · MD
Androgen Receptor Action in Castration Resistant Prostate Cancer
$1,431,923Steven P. Balk · Beth Israel Deaconess Medical Center · P01 · FY2023 · CA
MSKCC Center for Molecular Imaging in Cancer
$1,431,511Steven M Larson · Sloan-Kettering Inst Can Research · P50 · FY2012 · CA
Signal Transduction in Oncogenesis
$1,431,411University Of California Los Angeles · P01 · FY2002 · CA
Deep South CanCORS Colorectal and Lung Cancer PDCR Site
$1,431,241University Of Alabama At Birmingham · U01 · FY2005 · CA
NRG Oncology Network Group Operations Center
$1,430,323Norman Wolmark · Nrg Oncology Foundation, Inc. · U10 · FY2019 · CA
Androgen Receptor Action in Castration Resistant Prostate Cancer
$1,429,408Steven P. Balk · Beth Israel Deaconess Medical Center · P01 · FY2022 · CA
Radiation Oncology-Biology Integration Network on Oligometastasis (ROBIN OligoMET) Center
$1,428,096Phuoc T. Tran · University Of Maryland Baltimore · U54 · FY2024 · CA
3D CONFORMAL RADIATION THERAPY
$1,428,032Sloan-Kettering Institute For Cancer Res · P01 · FY2001 · CA
UNMC Eppley Cancer Center Support Grant
$1,427,680Kenneth Cowan · University Of Nebraska Medical Center · P30 · FY2012 · CA
FUSION GENES PREDICT PROSTATE CANCER RECURRENCE
$1,427,238University Of Pittsburgh - Of The Commonwealth System Of Higher Education · · FY2016 · Department of the Army
Photodynamic Therapy - Basic Science Studies
$1,425,632Fred W Hetzel · University Of Colorado Denver · P01 · FY2006 · CA
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers
$1,423,817Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Engineering HCC-selective PET agent
$1,423,458Freddy Escorcia · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Mu Center for Botanical Interaction Studies
$1,421,849Dennis B Lubahn · University Of Missouri-Columbia · P50 · FY2013 · AT
Mu Center for Botanical Interaction Studies
$1,421,727Dennis B Lubahn · University Of Missouri-Columbia · P50 · FY2014 · AT
Comprehensive SDSU-UCSD Cancer Center Partnership (2 of 2)
$1,421,400Ana M Navarro · University Of California, San Diego · U54 · FY2008 · CA
In vivo efficacy, safety and PK/PD analysis of SYN101, a first in class, immune cell targeted TGFb therapy for cancer patients
$1,420,853Dori A Thomas-Karyat · Synthis Therapeutics, Inc. · R44 · FY2025 · CA